バイオテクノロジーにおける培地・血清・試薬の世界市場

世界のバイオテクノロジーにおける培地・血清・試薬の市場規模は、2024年の63億米ドルから、予測期間中はCAGR 8.1%で推移し、2029年末には93億米ドルに達すると予測されています。

北米市場は、2024年の23億米ドルから、予測期間中はCAGR 8.4%で推移し、2029年末には35億米ドルに達すると予測されています。欧州市場は、2024年の18億米ドルから、CAGR 7.4%で推移し、2029年末には25億米ドルに達すると予測されています。

当レポートでは、世界のバイオテクノロジーにおける培地・血清・試薬の市場を調査し、市場概要、市場影響因子および市場機会の分析、法規制環境、新興技術および技術開発の動向、市場規模の推移・予測、各種区分・地域別の詳細分析、競合情勢、主要企業のプロファイルなどをまとめています。

目次

第1章 エグゼクティブサマリー

• 市場見通し
• 調査範囲
• 市場分析

第2章 市場概要

• 細胞培養の種類
• 一次培養
• 二次培養
• 培養培地の基本成分
• バッファリングシステム
• フェノールレッド
• 無機塩
• アミノ酸
• 炭水化物
• タンパク質とペプチド
• 脂肪酸と脂質
• ビタミン
• 微量元素
• 培地サプリメント
• 抗生物質
• 血清
• 細胞培養用途

第3章 市場力学

• 市場力学：スナップショット
• 市場促進要因
• バイオ医薬品への投資の増加
• 個別化医療の需要の増加
• 技術の進歩
• 高齢化人口の増加と慢性疾患の増加
• 市場抑制要因
• 倫理的問題と規制上の制約
• 熟練した専門家の不足とバイオ医薬品開発の高コスト
• 市場機会
• 3D細胞培養の需要の高まり
• 新興国におけるバイオ医薬品の需要の増加

第4章 新興技術

• 新興技術
• 細胞培養におけるAI/MLの応用
• 使い捨て技術
• 特許分析
• 細胞培養培地
• 細胞培養試薬

第5章 規制シナリオ

• 世界市場における規制状況
• 細胞培養培地
• 血清

第6章 市場セグメンテーション分析

• 世界市場の洞察
• セグメンテーションの内訳
• 市場分析：製品タイプ別
• 試薬
• 培地
• 血清
• 市場分析：エンドユーザー別
• バイオ医薬品企業
• 学術研究機関
• CDMO/CRO
• その他
• 地理的内訳
• 市場分析：地域別
• 北米
• 欧州
• アジア太平洋
• その他の地域

第7章 競合情報

• 概要
• 市場ランキング分析
• 戦略的取り組み
• M&A活動
• 投資と拡張
• 製品紹介

第8章 バイオテクノロジーにおける培地・血清・試薬市場の持続可能性：ESGの観点

• ESG：イントロダクション
• ESGの持続可能性の動向と取り組み
• 環境への取り組み
• 社会とガバナンスの取り組み
• ガバナンスの取り組み
• ESGリスク評価分析
• BCCによる総論

第9章 付録

• 調査手法
• 出典
• 略語
• 企業プロファイル
• ATCC
• BD
• BIO-TECHNE
• BIOWEST
• CORNING INC.
• DANAHER CORP.
• FUJIFILM IRVINE SCIENTIFIC
• LONZA
• MERCK KGAA
• MILTENYI BIOTEC
• PROMOCELL GMBH
• REPROCELL INC.
• SARTORIUS AG
• STEMCELL TECHNOLOGIES
• THERMO FISHER SCIENTIFIC INC.

List of Tables

• Summary Table : Global Market for Media, Sera and Reagents in Biotechnology, by Region, Through 2029
• Table 1 : Primary Versus Continuous Cell Lines
• Table 2 : Medicines in Development, by Select Disease Category, 2020
• Table 3 : Incidence and Mortality Rates of Cancer Across Regions, 2022
• Table 4 : Global Market for Media, Sera and Reagents in Biotechnology, by Product Type, Through 2029
• Table 5 : Global Market for Cell Culture Reagents, by Reagent Type, Through 2029
• Table 6 : Global Market for Cell Culture Reagents, by Region, Through 2029
• Table 7 : Global Market for Cell Culture Media, by Region, Through 2029
• Table 8 : Global Market for Cell Culture Media, by Sera, Through 2029
• Table 9 : Global Market for Cell Culture Media, by Formulation, Through 2029
• Table 10 : Global Market for Cell Culture Media, by Composition, Through 2029
• Table 11 : Global Market for Cell Culture Sera, by Region, Through 2029
• Table 12 : Global Market for Cell Culture Sera, by Type, Through 2029
• Table 13 : Global Market for Media, Sera and Reagents in Biotechnology, by End User, Through 2029
• Table 14 : Global Market for Media, Sera and Reagents Use in Biopharmaceutical Companies, by Region, Through 2029
• Table 15 : Global Market for Media, Sera and Reagents Use in Academic Research Institutes, by Region, Through 2029
• Table 16 : Global Market for Media, Sera and Reagents Use in CDMOs/CROs, by Region, Through 2029
• Table 17 : Global Market for Media, Sera and Reagents in Other End Uses, by Region, Through 2029
• Table 18 : Global Market for Media, Sera and Reagents in Biotechnology, by Region, Through 2029
• Table 19 : North American Market for Media, Sera and Reagents in Biotechnology, by Country, Through 2029
• Table 20 : North American Market for Media, Sera and Reagents in Biotechnology, by Product Type, Through 2029
• Table 21 : North American Market for Cell Culture Reagents, by Reagent Type, Through 2029
• Table 22 : North American Market for Cell Culture Media, by Sera, Through 2029
• Table 23 : North American Market for Cell Culture Media, by Formulation, Through 2029
• Table 24 : North American Market for Cell Culture Media, by Composition, Through 2029
• Table 25 : North American Market for Cell Culture Sera, by Type, Through 2029
• Table 26 : North American Market for Media, Sera and Reagents in Biotechnology, by End User, Through 2029
• Table 27 : The U.S. Market for Media, Sera and Reagents in Biotechnology, by Product Type, Through 2029
• Table 28 : The U.S. Market for Media, Sera and Reagents in Biotechnology, by End User, Through 2029
• Table 29 : Canadian Market for Media, Sera and Reagents in Biotechnology, by Product Type, Through 2029
• Table 30 : Canadian Market for Media, Sera and Reagents in Biotechnology, by End User, Through 2029
• Table 31 : Mexican Market for Media, Sera and Reagents in Biotechnology, by Product Type, Through 2029
• Table 32 : Mexican Market for Media, Sera and Reagents in Biotechnology, by End User, Through 2029
• Table 33 : European-Based Companies' R&D Expenditures and Comparison of Their Net Sales, 2023
• Table 34 : European Market for Media, Sera and Reagents in Biotechnology, by Country, Through 2029
• Table 35 : European Market for Media, Sera and Reagents in Biotechnology, by Product Type, Through 2029
• Table 36 : European Market for Cell Culture Reagents, by Reagent Type, Through 2029
• Table 37 : European Market for Cell Culture Media, by Sera, Through 2029
• Table 38 : European Market for Cell Culture Media, by Formulation, Through 2029
• Table 39 : European Market for Cell Culture Media, by Composition, Through 2029
• Table 40 : European Market for Cell Culture Sera, by Type, Through 2029
• Table 41 : European Market for Media, Sera and Reagents in Biotechnology, by End User, Through 2029
• Table 42 : German Market for Media, Sera and Reagents in Biotechnology, by Product Type, Through 2029
• Table 43 : German Market for Media, Sera and Reagents in Biotechnology, by End User, Through 2029
• Table 44 : French Market for Media, Sera and Reagents in Biotechnology, by Product Type, Through 2029
• Table 45 : French Market for Media, Sera and Reagents in Biotechnology, by End User, Through 2029
• Table 46 : Italian Market for Media, Sera and Reagents in Biotechnology, by Product Type, Through 2029
• Table 47 : Italian Market for Media, Sera and Reagents in Biotechnology, by End User, Through 2029
• Table 48 : Spanish Market for Media, Sera and Reagents in Biotechnology, by Product Type, Through 2029
• Table 49 : Spanish Market for Media, Sera and Reagents in Biotechnology, by End User, Through 2029
• Table 50 : The U.K. Market for Media, Sera and Reagents in Biotechnology, by Product Type, Through 2029
• Table 51 : The U.K. Market for Media, Sera and Reagents in Biotechnology, by End User, Through 2029
• Table 52 : Rest of European Market for Media, Sera and Reagents in Biotechnology, by Product Type, Through 2029
• Table 53 : Rest of European Market for Media, Sera and Reagents in Biotechnology, by End User, Through 2029
• Table 54 : Asia-Pacific Market for Media, Sera and Reagents in Biotechnology, by Country, Through 2029
• Table 55 : Asia-Pacific Market for Media, Sera and Reagents in Biotechnology, by Product Type, Through 2029
• Table 56 : Asia-Pacific Market for Cell Culture Reagents, by Reagent Type, Through 2029
• Table 57 : Asia-Pacific Market for Cell Culture Media, by Sera, Through 2029
• Table 58 : Asia-Pacific Market for Cell Culture Media, by Formulation, Through 2029
• Table 59 : Asia-Pacific Market for Cell Culture Media, by Composition, Through 2029
• Table 60 : Asia-Pacific Market for Cell Culture Sera, by Type, Through 2029
• Table 61 : Asia-Pacific Market for Media, Sera and Reagents in Biotechnology, by End User, Through 2029
• Table 62 : Chinese Market for Media, Sera and Reagents in Biotechnology, by Product Type, Through 2029
• Table 63 : Chinese Market for Media, Sera and Reagents in Biotechnology, by End User, Through 2029
• Table 64 : Japanese Market for Media, Sera and Reagents in Biotechnology, by Product Type, Through 2029
• Table 65 : Japanese Market for Media, Sera and Reagents in Biotechnology, by End User, Through 2029
• Table 66 : Indian Market for Media, Sera and Reagents in Biotechnology, by Product Type, Through 2029
• Table 67 : Indian Market for Media, Sera and Reagents in Biotechnology, by End User, Through 2029
• Table 68 : South Korean Market for Media, Sera and Reagents in Biotechnology, by Product Type, Through 2029
• Table 69 : South Korean Market for Media, Sera and Reagents in Biotechnology, by End User, Through 2029
• Table 70 : Rest of Asia-Pacific Market for Media, Sera and Reagents in Biotechnology, by Product Type, Through 2029
• Table 71 : Rest of Asia-Pacific Market for Media, Sera and Reagents in Biotechnology, by End User, Through 2029
• Table 72 : RoW Market for Media, Sera and Reagents in Biotechnology, by Product Type, Through 2029
• Table 73 : RoW Market for Cell Culture Reagents, by Reagent Type, Through 2029
• Table 74 : RoW Market for Cell Culture Media, by Sera, Through 2029
• Table 75 : RoW Market for Cell Culture Media, by Formulation, Through 2029
• Table 76 : RoW Market for Cell Culture Media, by Composition, Through 2029
• Table 77 : RoW Market for Cell Culture Sera, by Type, Through 2029
• Table 78 : RoW Market for Media, Sera and Reagents in Biotechnology, by End User, Through 2029
• Table 79 : Global Ranking of Manufacturers in Media, Sera and Reagents Market, 2023
• Table 80 : Partnerships, Agreements and Collaborations in Media, Sera and Reagents in the Biotechnology Industry, 2021-2025
• Table 81 : Merger and Acquisition Activities in Media, Sera and Reagents in the Biotechnology Market, 2022-2024
• Table 82 : Recent Investment and Expansion Activities in Media, Sera and Reagents in the Biotechnology Market, 2022-2024
• Table 83 : Recent Product Innovations in the Cell Culture Media, Sera and Reagents Market, 2021-2024
• Table 84 : Environmental Initiatives by Various Suppliers of Media, Sera and Reagents in the Biotechnology Market
• Table 85 : Key Social and Governance Issues in the Media, Sera and Reagents Biotechnology Market
• Table 86 : ESG Risk Ratings for Companies in the Media, Sera and Reagents Market, 2023
• Table 87 : Information Sources for this Report
• Table 88 : Abbreviations Used in the Media, Sera and Reagents in Biotechnology Market
• Table 89 : ATCC: Company Snapshot
• Table 90 : ATCC: Product Portfolio
• Table 91 : ATCC: News/Key Developments, 2023 and 2024
• Table 92 : BD: Company Snapshot
• Table 93 : BD: Financial Performance, FY 2023 and 2024
• Table 94 : BD: Product Portfolio
• Table 95 : BD: News/Key Developments, 2022-2024
• Table 96 : Bio-Techne: Company Snapshot
• Table 97 : Bio-Techne: Financial Performance, FY 2022 and 2023
• Table 98 : Bio-Techne: Product Portfolio
• Table 99 : Bio-Techne: News/Key Developments, 2021-2024
• Table 100 : Biowest.: Company Snapshot
• Table 101 : Biowest: Product Portfolio
• Table 102 : Corning Inc.: Company Snapshot
• Table 103 : Corning Inc.: Financial Performance, FY 2022 and 2023
• Table 104 : Corning Inc.: Product Portfolio
• Table 105 : Corning Inc.: News/Key Developments, 2022 and 2023
• Table 106 : Danaher Corp.: Company Snapshot
• Table 107 : Danaher Corp.: Financial Performance, FY 2022 and 2023
• Table 108 : Danaher Corp.: Product Portfolio
• Table 109 : Danaher Corp.: News/Key Developments, 2021-2023
• Table 110 : Fujifilm Irvine Scientific: Company Snapshot
• Table 111 : Fujifilm Irvine Scientific: Product Portfolio
• Table 112 : Fujifilm Irvine Scientific: News/Key Developments, 2022-2024
• Table 113 : Lonza: Company Snapshot
• Table 114 : Lonza: Financial Performance, FY 2022 and 2023
• Table 115 : Lonza: Product Portfolio
• Table 116 : Lonza: News/Key Developments, 2023 and 2024
• Table 117 : Merck KGaA: Company Snapshot
• Table 118 : Merck KGaA: Financial Performance, FY 2022 and 2023
• Table 119 : Merck KGaA.: Product Portfolio
• Table 120 : Merck KGaA: News/Key Developments, 2021-2025
• Table 121 : Miltenyi Biotec: Company Snapshot
• Table 122 : Miltenyi Biotec: Product Portfolio
• Table 123 : Miltenyi Biotec: News/Key Developments, 2023 and 2024
• Table 124 : PromoCell GmbH.: Company Snapshot
• Table 125 : PromoCell GmbH.: Product Portfolio
• Table 126 : PromoCell GmbH.: News/Key Developments, 2023 and 2024
• Table 127 : REPROCELL Inc.: Company Snapshot
• Table 128 : REPROCELL Inc.: Financial Performance, FY 2022 and 2023
• Table 129 : REPROCELL Inc.: Product Portfolio
• Table 130 : REPROCELL Inc.: News/Key Developments, 2021-2025
• Table 131 : Sartorius AG: Company Snapshot
• Table 132 : Sartorius AG: Financial Performance, FY 2022 and 2023
• Table 133 : Sartorius AG: Product Portfolio
• Table 134 : Sartorius AG: News/Key Developments, 2023 and 2024
• Table 135 : STEMCELL Technologies: Company Snapshot
• Table 136 : STEMCELL Technologies: Product Portfolio
• Table 137 : STEMCELL Technologies: News/Key Developments, 2021-2024
• Table 138 : Thermo Fisher Scientific Inc.: Company Snapshot
• Table 139 : Thermo Fisher Scientific Inc.: Financial Performance, FY 2022 and 2023
• Table 140 : Thermo Fisher Scientific Inc.: Product Portfolio
• Table 141 : Thermo Fisher Scientific Inc.: News/Key Developments, 2021-2024

List of Figures

• Summary Figure : Global Market for Media, Sera and Reagents in Biotechnology, by Region, 2021-2029
• Figure 1 : Cell Culture Timeline
• Figure 2 : Market Dynamics of Global Media, Sera and Reagents in Biotechnology
• Figure 3 : Venture Averages for Biopharma Therapeutics and Platform Companies, 2010-2024
• Figure 4 : Personalized Medicines' Contribution to the Total FDA Approvals, 2015-2023
• Figure 5 : Patents Documented on Cell Culture Media, by Top Applicants, 2021-January, 2025
• Figure 6 : Share of Patents on Cell Culture Media, by Patent Jurisdiction, 2021-January 2025
• Figure 7 : Patents Documented on Cell Culture Media Over Time, 2010-January 2025
• Figure 8 : Patents Documented on Cell Culture Reagents, by Top Applicants, 2021-January 2025
• Figure 9 : Share of Patents on Cell Culture Reagents, by Jurisdiction, 2021-January 2025
• Figure 10 : Patents Documented on Cell Culture Reagents Over Time, 2010-January 2025
• Figure 11 : Global Market Shares of Media, Sera and Reagents in Biotechnology, by Product Type, 2023
• Figure 12 : Global Market Shares of Cell Culture Reagents, by Reagent Type, 2023
• Figure 13 : Global Market Shares of Cell Culture Media, by Sera, 2023
• Figure 14 : Global Market Shares of Cell Culture Media, by Formulation, 2023
• Figure 15 : Global Market Shares of Cell Culture Media, by Composition, 2023
• Figure 16 : Global Market Shares of Cell Culture Sera, by Type, 2023
• Figure 17 : Global Market Shares of Media, Sera and Reagents in Biotechnology, by End User, 2023
• Figure 18 : Global Market Shares of Media, Sera and Reagents in Biotechnology, by Region, 2023
• Figure 19 : North American Market Shares of Media, Sera and Reagents in Biotechnology, by Country, 2023
• Figure 20 : The U.S. NIH Funding in Healthcare Research and Development Activities, 2010-2023
• Figure 21 : Number of Novel Drug Approvals by U.S. FDA, by Drug Biologic Type, 2020-2024
• Figure 22 : European Market Shares of Media, Sera and Reagents in Biotechnology, by Country, 2023
• Figure 23 : Asia-Pacific Market Shares of Media, Sera and Reagents in Biotechnology, by Country, 2023
• Figure 24 : Global Market Shares of Media, Sera and Reagents in Biotechnology, by Manufacturer/Supplier, 2023
• Figure 25 : Advantages of ESG for the Companies in Cell Culture Media, Sera and Reagents
• Figure 26 : BD: Revenue Shares, by Business Unit, FY 2024
• Figure 27 : BD: Revenue Shares, by Country/Region, FY 2024
• Figure 28 : Bio-Techne: Revenue Shares, by Business Unit, FY 2023
• Figure 29 : Bio-Techne: Revenue Shares, by Country/Region, FY 2023
• Figure 30 : Corning Inc.: Revenue Shares, by Business Unit, FY 2023
• Figure 31 : Corning Inc.: Revenue Shares, by Country/Region, FY 2023
• Figure 32 : Danaher Corp.: Revenue Shares, by Business Unit, FY 2023
• Figure 33 : Danaher Corp.: Revenue Shares, by Country/Region, FY 2023
• Figure 34 : Lonza: Revenue Shares, by Business Unit, FY 2023
• Figure 35 : Lonza: Revenue Shares, by Country/Region, FY 2023
• Figure 36 : Merck KGaA: Revenue Shares, by Business Unit, FY 2023
• Figure 37 : Merck KGaA: Revenue Shares, by Country/Region, FY 2023
• Figure 38 : REPROCELL Inc.: Revenue Shares, by Business Unit, FY 2023
• Figure 39 : REPROCELL Inc.: Revenue Shares, by Country/Region, FY 2023
• Figure 40 : Sartorius AG: Revenue Shares, by Business Unit, FY 2023
• Figure 41 : Sartorius AG: Revenue Shares, by Country/Region, FY 2023
• Figure 42 : Thermo Fisher Scientific Inc.: Revenue Shares, by Business Unit, FY 2023
• Figure 43 : Thermo Fisher Scientific Inc.: Revenue Shares, by Country/Region, FY 2023

The global market for media, sera and reagents in biotechnology is expected to grow from $6.3 billion in 2024 and is projected to reach $9.3 billion by the end of 2029, at a compound annual growth rate (CAGR) of 8.1% during the forecast period of 2024 to 2029.

The North American market for media, sera and reagents in biotechnology is expected to grow from $2.3 billion in 2024 and is projected to reach $3.5 billion by the end of 2029, at a CAGR of 8.4% during the forecast period of 2024 to 2029.

The European market for media, sera and reagents in biotechnology is expected to grow from $1.8 billion in 2024 and is projected to reach $2.5 billion by the end of 2029, at a CAGR of 7.4% during the forecast period of 2024 to 2029.

Report Scope

This report highlights current and future market potential for media, sera and reagents in biotechnology. It provides a detailed analysis of the market drivers, restraints and opportunities. The report includes detailed information on emerging technologies, patent analysis, ESG development, investment outlook and deals. The report also covers market projections through 2029 and presents a competitive landscape. The report provides market estimates and forecasts based on product type, end user and region. The market is segmented by product type into reagents, media and sera. The reagents market is segmented into reagents: biological response modifiers, cell dissociation reagents and others (amino acids, antibiotics, etc.). Market analysis in the media segment is divided into specialty and classical media based on composition. The media are divided into powdered and ready-to-use liquid media based on formulation. Based on serum components, media are segmented into serum-free and serum-requiring media. The market for sera is segmented based on the source of serum into fetal bovine serum and other sera, including from animal sources such as goats, porcine, rabbits, etc. By end user, the market is segmented into biopharmaceutical companies, academic research institutes, contract research organizations and others. The report includes profiles of the key companies with detailed information about their business segments, financials, product portfolios and recent developments.

The market is segregated by geographical region into North America, Europe, Asia-Pacific and the Rest of the World. The North American region includes the U.S., Canada and Mexico. Europe includes Germany, the U.K., Italy, France, Spain and the Rest of Europe; Asia-Pacific includes China, Japan, India, South Korea and the Rest of Asia-Pacific. For market estimates, data is provided for 2021 and 2022 as the historical years, 2023 as the base year and 2029 as the forecast year.

Report Includes

• 87 data tables and 55 additional tables
• An analysis of the global market for media, sera and reagents in the biotech industry
• Analyses of the global market trends, with sales data for 2021-2023, estimates for 2024, and projections of compound annual growth rates (CAGRs) through 2029
• Evaluation of the overall market size for media, sera and reagents and their corresponding market share analysis by product type, end use and region
• Discussion of the market potential, and forecasts for the market's segments and sub-segments
• In-depth information concerning market drivers, opportunities, challenges and other demographic and economic factors that will drive demand for media, sera and reagents
• Review of the current market status, key technology issues, industry value chain, Porter's Five Forces, competitive landscape and R&D activity
• A discussion of the industry's ESG challenges and practices
• Market share analysis of the key companies in the industry and coverage of their proprietary technologies, strategic alliances, and other market strategies
• Profiles of the leading companies

Table of Contents

Chapter 1 Executive Summary

• Market Outlook
• Scope of Report
• Market Insights

Chapter 2 Market Overview

• Introduction
• Types of Cell Culture
• Primary Culture
• Secondary Culture
• Basic Components of Culture Media
• Buffering Systems
• Phenol Red
• Inorganic Salts
• Amino Acids
• Carbohydrates
• Proteins and Peptides
• Fatty Acids and Lipids
• Vitamins
• Trace Elements
• Media Supplements
• Antibiotics
• Serum
• Cell Culture Applications

Chapter 3 Market Dynamics

• Market Dynamics Snapshot
• Market Drivers
• Rising Investments in Biopharmaceuticals
• Increasing Demand for Personalized Medicines
• Technological Advances
• Rising Aging Population and the Growing Prevalence of Chronic Diseases
• Market Restraints
• Ethical Issues and Regulatory Constraints
• Lack of Skilled Professionals and High Cost of Biopharmaceutical Development
• Market Opportunities
• Rising Demand for 3D Cell Cultures
• Rising Demand for Biopharmaceuticals in Emerging Countries

Chapter 4 Emerging Technologies

• Introduction
• Emerging Technologies
• Application of AI/ML in Cell Culture
• Single Use Technologies
• Patent Analysis
• Cell Culture Media
• Cell Culture Reagents

Chapter 5 Regulatory Scenario

• Regulatory Landscape in the Global Market
• Cell Culture Media
• Sera

Chapter 6 Market Segmentation Analysis

• Global Market Insights
• Segmentation Breakdown
• Market Analysis by Product Type
• Reagents
• Media
• Sera
• Market Analysis by End User
• Biopharmaceutical Companies
• Academic Research Institutes
• Contract Manufacturing and Development Organizations (CDMOs/CROs)
• Other End Users
• Geographic Breakdown
• Market Analysis by Region
• North America
• Europe
• Asia-Pacific
• Rest of the World (RoW)

Chapter 7 Competitive Intelligence

• Overview
• Market Rankings Analysis
• Strategic Initiatives
• M&A Activities
• Investments and Expansions
• Product Introductions

Chapter 8 Sustainability in the Media, Sera and Reagents in Biotechnology Market: An ESG Perspective

• Introduction to ESG
• ESG Sustainability Trends and Initiatives
• Environmental Initiatives
• Social and Governance Initiatives
• Governance Initiatives
• ESG Risk Ratings Analysis
• Concluding Remarks from BCC

Chapter 9 Appendix

• Methodology
• Sources
• Abbreviations
• Company Profiles
• ATCC
• BD
• BIO-TECHNE
• BIOWEST
• CORNING INC.
• DANAHER CORP.
• FUJIFILM IRVINE SCIENTIFIC
• LONZA
• MERCK KGAA
• MILTENYI BIOTEC
• PROMOCELL GMBH
• REPROCELL INC.
• SARTORIUS AG
• STEMCELL TECHNOLOGIES
• THERMO FISHER SCIENTIFIC INC.